Western blot analyses of insulin signaling pathways showed that ALA can improve insulin sensitivity in the brain of T2DM rats, activate insulin signaling pathways, and inhibit the activity of GSK-3β. This evidence concerns the gene GSK3B and type 2 diabetes mellitus.